Related Experiment Video
Updated: Mar 16, 2026
07:29
Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
12.4K
[Radiotherapy for nasopharyngeal carcinoma]
P Maingon1, P Blanchard2, F Bidault3
1Département de radiothérapie, centre Georges-François-Leclerc, 1, rue du Professeur-Marion, 21079 Dijon cedex, France.
Summary
Nasopharyngeal carcinoma (NPC) is often diagnosed at advanced stages. Early-stage NPC shows good prognosis with radiotherapy alone, while advanced stages benefit from chemoradiation, with careful monitoring for treatment adaptation.
Area of Science:
- Oncology
- Radiation Oncology
- Medical Oncology
Background:
- Nasopharyngeal carcinoma (NPC) is a rare malignancy.
- Diagnosis frequently occurs at advanced stages.
- Early-stage (T1-T2 NO) NPC has a favorable prognosis, with radiotherapy alone achieving over 90% local control.
Purpose of the Study:
- To outline the management of nasopharyngeal carcinoma based on disease stage.
- To highlight treatment strategies for localized, locally advanced, and recurrent NPC.
- To emphasize the importance of multidisciplinary tumor boards in treatment planning.
Main Methods:
- Review of current treatment paradigms for nasopharyngeal carcinoma.
- Discussion of radiotherapy, chemoradiation, and surgical interventions.
- Consideration of adaptive dosimetric revisions and reirradiation strategies.
Main Results:
- Radiotherapy alone is effective for localized T1-T2 NO NPC.
- Combined chemoradiation is the standard for locally advanced disease.
- Recurrent NPC management requires careful consideration of surgical options and reirradiation.
Conclusions:
- Treatment strategies for nasopharyngeal carcinoma vary significantly by stage.
- Vigilant monitoring for treatment response and potential recurrence is crucial.
- Multidisciplinary evaluation is essential for optimizing outcomes in recurrent or complex cases.
